Clara Chen

3.9k total citations
101 papers, 2.6k citations indexed

About

Clara Chen is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Clara Chen has authored 101 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 29 papers in Hematology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Clara Chen's work include Multiple Myeloma Research and Treatments (18 papers), Prostate Cancer Treatment and Research (12 papers) and Adrenal and Paraganglionic Tumors (11 papers). Clara Chen is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Prostate Cancer Treatment and Research (12 papers) and Adrenal and Paraganglionic Tumors (11 papers). Clara Chen collaborates with scholars based in United States, United Kingdom and Canada. Clara Chen's co-authors include Tuhina Neogi, Yuqing Zhang, David J. Hunter, Christine E. Chaisson, Hyon K. Choi, James L. Gulley, William L. Dahut, Seth M. Steinberg, Elizabeth C. Jones and J. Scott Roberts and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Clara Chen

94 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara Chen United States 24 832 604 504 449 402 101 2.6k
Shih-Jen Hwang United States 21 1.0k 1.3× 1.6k 2.6× 501 1.0× 759 1.7× 533 1.3× 27 4.3k
Nicolas Pallet France 34 295 0.4× 1.2k 2.0× 285 0.6× 613 1.4× 613 1.5× 123 3.4k
Chad Deal United States 27 1.1k 1.4× 1.2k 2.0× 194 0.4× 164 0.4× 527 1.3× 62 3.9k
Anne Tang United States 24 1.2k 1.4× 1.0k 1.7× 171 0.3× 136 0.3× 272 0.7× 54 3.1k
Seung Hee Yang South Korea 27 245 0.3× 562 0.9× 450 0.9× 754 1.7× 244 0.6× 126 2.2k
Rong Huang China 26 776 0.9× 611 1.0× 542 1.1× 200 0.4× 256 0.6× 116 2.1k
Xīn Gào United States 31 919 1.1× 1.2k 2.1× 301 0.6× 66 0.1× 473 1.2× 187 4.0k
George Bayliss United States 25 207 0.2× 833 1.4× 658 1.3× 617 1.4× 211 0.5× 70 2.3k
Chen Yuan China 31 851 1.0× 930 1.5× 252 0.5× 102 0.2× 709 1.8× 121 3.3k
Yanlin Wang China 26 184 0.2× 737 1.2× 469 0.9× 547 1.2× 286 0.7× 91 2.0k

Countries citing papers authored by Clara Chen

Since Specialization
Citations

This map shows the geographic impact of Clara Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Chen more than expected).

Fields of papers citing papers by Clara Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Chen. The network helps show where Clara Chen may publish in the future.

Co-authorship network of co-authors of Clara Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Chen. A scholar is included among the top collaborators of Clara Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Chen. Clara Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Latimer, Nicholas, et al.. (2024). An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?. PharmacoEconomics. 42(12). 1395–1412. 1 indexed citations
2.
Taylor, Kurt, Nicholas Latimer, Thomas Douglas, et al.. (2024). Treatment Effect Waning in Immuno-oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence with Proposals to Guide Modelling. PharmacoEconomics. 42(11). 1181–1196. 2 indexed citations
5.
Marzolini, Susan, Damien Gallagher, Walter Swardfager, et al.. (2023). The effect of exercise on blood concentrations of angiogenesis markers in older adults: A systematic review and meta-analysis. Neurobiology of Aging. 135. 15–25. 16 indexed citations
7.
Ansari, Khairul I., Arunoday Bhan, Antariksh Tyagi, et al.. (2021). Autocrine GMCSF Signaling Contributes to Growth of HER2+ Breast Leptomeningeal Carcinomatosis. Cancer Research. 81(18). 4723–4735. 9 indexed citations
8.
Yokose, Chio, Natalie McCormick, Clara Chen, et al.. (2019). Risk of gout flares after vaccination: a prospective case cross-over study. Annals of the Rheumatic Diseases. 78(11). 1601–1604. 17 indexed citations
9.
Weisel, Katja, Agne Paner, Monika Engelhardt, et al.. (2019). Impact of Elotuzumab Plus Pomalidomide and Dexamethasone on Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Enrolled in the ELOQUENT-3 Study. Blood. 134(Supplement_1). 3480–3480. 3 indexed citations
10.
Vij, Ravi, Clara Chen, Brian G.M. Durie, et al.. (2017). Treatment Patterns and Associated Outcomes in Patients with Relapsed or Refractory Multiple Myeloma in the US and Non-US Countries: Findings from Preamble. Blood. 130. 3123–3123. 2 indexed citations
12.
Shuch, Brian, Lambros Stamatakis, Clara Chen, et al.. (2014). Utility of 2-(18F) fluoro-2 deoxy-D-glucose PET/CT in advanced papillary renal cell carcinoma.. Journal of Clinical Oncology. 32(4_suppl). 419–419. 2 indexed citations
13.
Lee, Jae‐Ho, Vladimir Malinin, Zhili Li, et al.. (2013). 99m Tc-labeled therapeutic inhaled amikacin loaded liposomes. Journal of Liposome Research. 23(4). 336–342. 11 indexed citations
14.
Shuch, Brian, Clara Chen, Kelly Lin, et al.. (2013). Clinical evaluation of 2-(18F) fluoro-2 deoxy-D-glucose PET/ CT in hereditary leiomyomatosis and renal cell carcinoma.. Journal of Clinical Oncology. 31(6_suppl). 383–383. 2 indexed citations
15.
Walley, Alexander Y., et al.. (2012). Methadone Dose, Take Home Status, and Hospital Admission Among Methadone Maintenance Patients. Journal of Addiction Medicine. 6(3). 186–190. 32 indexed citations
16.
Muehlenbein, Catherine E., et al.. (2011). Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 2011. 1–5. 6 indexed citations
17.
Chen, Clara, et al.. (2011). Willingness to Pay for Genetic Testing for Alzheimer's Disease: A Measure of Personal Utility. Genetic Testing and Molecular Biomarkers. 15(12). 871–875. 48 indexed citations
18.
Abraham, Jame, Maureen Edgerly, Richard H. Wilson, et al.. (2009). A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine. Clinical Cancer Research. 15(10). 3574–3582. 93 indexed citations
19.
Figg, William D., Haiqing Li, Tristan M. Sissung, et al.. (2007). Pre‐clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen‐independent prostate cancer. British Journal of Urology. 99(5). 1047–1055. 34 indexed citations
20.
Bates, Susan E., Clara Chen, Robert W. Robey, et al.. (2002). Reversal of Multidrug Resistance: Lessons from Clinical Oncology. Novartis Foundation symposium. 243. 83–102. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026